Clinical trial
Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC
NCT01775943
Drugs and interventions used in this trial
0 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No interventions are currently published for this study in CureCurrent. View the original registry record below.
Study at a glance
Registry-backedEfficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC
Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Neoplasmsverified · MONDO: lung neoplasm
Interventions
Sponsors & collaborators
Ulsan University Hospitallead sponsor
AstraZenecacollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01775943 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.